Author + information
- Received October 2, 2015
- Revision received January 12, 2016
- Accepted January 28, 2016
- Published online April 1, 2016.
- Marysia S. Tweet, MDa,
- Rajiv Gulati, MD, PhDa,
- Eric E. Williamson, MDb,
- Terri J. Vrtiska, MDc and
- Sharonne N. Hayes, MDa,∗ ()
- aDivision of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
- bDivision of Cardiovascular Radiology, Department of Radiology, Mayo Clinic, Rochester, Minnesota
- cDivision of Abdominal Radiology, Department of Radiology, Mayo Clinic, Rochester, Minnesota
- ↵∗Reprint requests and correspondence:
Dr. Sharonne N. Hayes, Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First Street Southwest, Rochester, Minnesota 55905.
Spontaneous coronary artery dissection (SCAD) has gained attention as a key cause of acute coronary syndrome and sudden cardiac death among women. Recent advancements in cardiac imaging have improved identification and accelerated awareness of SCAD. Accurate diagnosis of SCAD through use of imaging is critical, as emerging evidence suggests that the optimal short- and long-term management strategies for women with SCAD differs substantially from that of women with atherosclerotic coronary disease. This review summarizes the application of both invasive and noninvasive imaging for the diagnosis, assessment, surveillance, and treatment of women affected by SCAD.
- cardiac imaging
- coronary angiography
- coronary computed tomography angiography
- fibromuscular dysplasia
- intravascular imaging
- myocardial infarction
- spontaneous coronary artery dissection
The Mayo Clinic SCAD and DNA Registries are funded in part by the Mayo Clinic Division of Cardiovascular Diseases and SCAD Research, Inc. All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received October 2, 2015.
- Revision received January 12, 2016.
- Accepted January 28, 2016.
- American College of Cardiology Foundation